Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional Study To Investigate The Effectiveness Of Atezolizumab Under Real-World Conditions In Patients With Inoperable Locally-Advanced Or Metastatic Urothelial Carcinoma Of The Urinary Tract (Announce)

NCT03399643 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT03399643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03399643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional Study To Investigate The Effectiveness Of Atezolizumab Under Real-World Conditions In Patients With Inoperable Locally-Advanced Or Metastatic Urothelial Carcinoma Of The Urinary Tract (Announce)
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Terminated
Start date
December 28, 2017
Completion date
January 28, 2019
Enrollment
22 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

urothelial carcinoma